STINCARDINI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 867
EU - Europa 498
AS - Asia 296
OC - Oceania 2
AF - Africa 1
Totale 1.664
Nazione #
US - Stati Uniti d'America 866
IT - Italia 173
IE - Irlanda 162
SG - Singapore 105
HK - Hong Kong 94
CN - Cina 50
DE - Germania 28
VN - Vietnam 23
GB - Regno Unito 20
FR - Francia 18
RU - Federazione Russa 18
SE - Svezia 17
BE - Belgio 14
AT - Austria 13
UA - Ucraina 7
CH - Svizzera 6
TR - Turchia 6
CZ - Repubblica Ceca 5
FI - Finlandia 5
JP - Giappone 5
GR - Grecia 4
KR - Corea 4
RO - Romania 4
IN - India 3
NL - Olanda 3
UZ - Uzbekistan 3
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
ID - Indonesia 1
LB - Libano 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 1.664
Città #
Chandler 217
Dublin 159
Hong Kong 93
Singapore 84
Ann Arbor 66
Boardman 56
San Mateo 53
Perugia 51
Santa Clara 41
Altamura 37
Medford 30
Princeton 30
Lawrence 27
Des Moines 24
Dong Ket 23
Wilmington 20
Andover 18
Brussels 14
Los Angeles 13
Beijing 12
Vienna 10
Redmond 9
Ashburn 7
Dearborn 7
Woodbridge 7
Falls Church 6
Kocaeli 6
Norwalk 6
Santarcangelo di Romagna 6
Shenzhen 6
Bologna 5
Camerino 5
Saint Petersburg 5
Brno 4
Cambridge 4
Milan 4
Munich 4
Rome 4
San Paolo di Civitate 4
Seoul 4
Timisoara 4
Turin 4
Chicago 3
Dallas 3
Florence 3
Lappeenranta 3
Macerata 3
Osaka 3
Pioltello 3
Castiglione del Lago 2
Chengdu 2
Chennai 2
Collazzone 2
Edinburgh 2
Hangzhou 2
Helsinki 2
Monreale 2
Morrovalle 2
Moscow 2
Nanjing 2
Nanning 2
Palermo 2
Redwood City 2
San Daniele del Friuli 2
Tokyo 2
Zhengzhou 2
Abidjan 1
Amsterdam 1
Aprilia 1
Birmingham 1
Boydton 1
Böblingen 1
Changzhou 1
Delhi 1
Den Haag 1
Fairfield 1
Frankfurt am Main 1
Fremont 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Hamilton 1
Houston 1
Hull 1
Marcallo con Casone 1
Medan 1
Montreal 1
Olomouc 1
Philadelphia 1
Pistoia 1
Shanghai 1
Sindelfingen 1
Sligo 1
Sofia 1
Terni 1
Trieste 1
Xiamen 1
Totale 1.275
Nome #
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 111
Cellular proteostasis: a new twist in the action of thymosin α1 78
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 67
Reply to ‘F508del-CFTR is not corrected by thymosin α1’ 67
The circadian protein PER1 modulates the cellular response to anticancer treatments 63
Microbes in the Era of Circadian Medicine 62
Thymosin alpha1 mitigates intestinal immunopathology on immune checkpoint inhibition 61
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 56
Tryptophan Co-Metabolism at the Host-Pathogen Interface 55
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease 55
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 53
Circadian Regulation of Xenobiotic Metabolism during Anticancer Treatment 53
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity 52
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease 51
Selectively targeting key inflammatory pathways in cystic fibrosis 50
Thymosin α1 protects from CTLA-4 intestinal immunopathology 50
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting 50
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 50
The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface 49
Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity 49
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 46
Thymosin alpha 1 in cystic fibrosis: from the lung to the gut 46
Tryptophan as a Central Hub for Host/Microbial Symbiosis 45
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk 44
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis 43
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 42
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 40
A Reappraisal of Thymosin Alpha1 in Cancer Therapy 39
A shifted composition of the lung microbiota conditions the antifungal response of immunodeficient mice 39
Thymosin β4 limits inflammation through autophagy 36
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis 34
Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis 27
The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections 23
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections 22
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 18
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 17
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia 13
The immune and microbial homeostasis determines the Candida–mast cells cross-talk in celiac disease 10
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 8
Totale 1.774
Categoria #
all - tutte 8.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 4 7 3 7 15 10 6 3
2020/2021148 1 16 5 2 46 2 11 2 13 17 5 28
2021/2022255 5 53 9 8 13 5 17 59 9 13 30 34
2022/2023692 35 122 8 57 94 75 7 36 229 5 19 5
2023/2024347 20 47 17 14 8 1 86 3 24 17 55 55
2024/2025189 11 50 13 60 55 0 0 0 0 0 0 0
Totale 1.774